Concepts (302)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood-Brain Barrier | 15 | 2019 | 34 | 2.890 |
Why?
|
| Alzheimer Disease | 15 | 2023 | 1320 | 2.060 |
Why?
|
| Brain | 23 | 2021 | 1203 | 2.030 |
Why?
|
| Aging | 17 | 2023 | 1102 | 1.790 |
Why?
|
| Brain Injuries | 7 | 2019 | 31 | 1.750 |
Why?
|
| TDP-43 Proteinopathies | 6 | 2023 | 83 | 1.690 |
Why?
|
| Lewy Bodies | 8 | 2023 | 146 | 1.530 |
Why?
|
| Amyotrophic Lateral Sclerosis | 3 | 2023 | 21 | 1.530 |
Why?
|
| Frontotemporal Lobar Degeneration | 3 | 2023 | 22 | 1.480 |
Why?
|
| DNA-Binding Proteins | 8 | 2023 | 228 | 1.400 |
Why?
|
| Olfaction Disorders | 2 | 2021 | 36 | 1.270 |
Why?
|
| Aged, 80 and over | 31 | 2023 | 3724 | 1.080 |
Why?
|
| Frontotemporal Dementia | 3 | 2023 | 11 | 1.030 |
Why?
|
| Cerebral Cortex | 5 | 2021 | 125 | 0.980 |
Why?
|
| Angiopoietin-1 | 6 | 2016 | 6 | 0.930 |
Why?
|
| Vascular Endothelial Growth Factor A | 7 | 2019 | 68 | 0.920 |
Why?
|
| Male | 44 | 2023 | 12459 | 0.920 |
Why?
|
| Lewy Body Disease | 3 | 2021 | 70 | 0.890 |
Why?
|
| Cognitive Dysfunction | 5 | 2023 | 737 | 0.870 |
Why?
|
| Dementia | 5 | 2019 | 388 | 0.830 |
Why?
|
| Rats | 15 | 2019 | 623 | 0.830 |
Why?
|
| Parkinsonian Disorders | 6 | 2023 | 164 | 0.790 |
Why?
|
| Animals | 21 | 2019 | 3270 | 0.790 |
Why?
|
| Substantia Nigra | 3 | 2021 | 101 | 0.760 |
Why?
|
| Humans | 55 | 2023 | 22912 | 0.760 |
Why?
|
| Brain Edema | 5 | 2011 | 16 | 0.750 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 96 | 0.730 |
Why?
|
| Amygdala | 1 | 2021 | 34 | 0.680 |
Why?
|
| Endothelium, Vascular | 8 | 2005 | 45 | 0.680 |
Why?
|
| Olfactory Bulb | 2 | 2023 | 12 | 0.670 |
Why?
|
| Female | 38 | 2023 | 12939 | 0.660 |
Why?
|
| Temporal Lobe | 2 | 2018 | 58 | 0.650 |
Why?
|
| Neocortex | 1 | 2019 | 22 | 0.610 |
Why?
|
| Longitudinal Studies | 9 | 2021 | 1046 | 0.610 |
Why?
|
| Cognition | 7 | 2021 | 948 | 0.590 |
Why?
|
| Immunohistochemistry | 7 | 2017 | 337 | 0.580 |
Why?
|
| Angiopoietin-2 | 4 | 2005 | 4 | 0.570 |
Why?
|
| Caveolin 1 | 4 | 2016 | 10 | 0.540 |
Why?
|
| Pituitary Neoplasms | 1 | 2017 | 14 | 0.530 |
Why?
|
| Proteins | 2 | 2011 | 51 | 0.520 |
Why?
|
| Rats, Wistar | 8 | 2019 | 54 | 0.510 |
Why?
|
| Aged | 22 | 2023 | 7442 | 0.480 |
Why?
|
| Memory Disorders | 1 | 2017 | 108 | 0.480 |
Why?
|
| Neuroprotective Agents | 1 | 2016 | 43 | 0.480 |
Why?
|
| Cerebral Ventricle Neoplasms | 2 | 2013 | 4 | 0.460 |
Why?
|
| Glioma, Subependymal | 2 | 2013 | 6 | 0.460 |
Why?
|
| Neovascularization, Pathologic | 4 | 2005 | 35 | 0.450 |
Why?
|
| Tight Junctions | 4 | 2011 | 18 | 0.450 |
Why?
|
| Spinal Cord | 4 | 2018 | 74 | 0.430 |
Why?
|
| Hippocampus | 1 | 2015 | 198 | 0.400 |
Why?
|
| Parkinson Disease | 5 | 2023 | 591 | 0.400 |
Why?
|
| Cerebral Amyloid Angiopathy | 3 | 2023 | 94 | 0.400 |
Why?
|
| Ependymoma | 1 | 2013 | 16 | 0.390 |
Why?
|
| Endothelial Cells | 2 | 2011 | 57 | 0.390 |
Why?
|
| Blood Vessels | 2 | 2011 | 14 | 0.390 |
Why?
|
| Brain Diseases | 4 | 2021 | 55 | 0.380 |
Why?
|
| Neuropsychological Tests | 7 | 2023 | 865 | 0.380 |
Why?
|
| Autopsy | 5 | 2021 | 255 | 0.370 |
Why?
|
| Cold Temperature | 4 | 2008 | 27 | 0.370 |
Why?
|
| Fibronectins | 5 | 2019 | 17 | 0.370 |
Why?
|
| Arteriolosclerosis | 3 | 2023 | 57 | 0.360 |
Why?
|
| Cognition Disorders | 5 | 2018 | 692 | 0.350 |
Why?
|
| Neurons | 5 | 2013 | 273 | 0.340 |
Why?
|
| Cell Adhesion Molecules | 2 | 2008 | 15 | 0.330 |
Why?
|
| RNA, Messenger | 4 | 2005 | 283 | 0.320 |
Why?
|
| Disease Progression | 5 | 2019 | 529 | 0.320 |
Why?
|
| Membrane Proteins | 2 | 2008 | 140 | 0.310 |
Why?
|
| Severity of Illness Index | 5 | 2021 | 801 | 0.310 |
Why?
|
| Gene Expression Regulation | 2 | 2008 | 226 | 0.300 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2023 | 859 | 0.300 |
Why?
|
| Microscopy, Electron | 3 | 2003 | 60 | 0.290 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2007 | 6 | 0.270 |
Why?
|
| Mycosis Fungoides | 1 | 2007 | 5 | 0.270 |
Why?
|
| Horseradish Peroxidase | 4 | 2016 | 4 | 0.270 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2007 | 27 | 0.270 |
Why?
|
| Muscular Diseases | 1 | 2007 | 17 | 0.270 |
Why?
|
| Depression | 3 | 2016 | 368 | 0.260 |
Why?
|
| Cerebrovascular Disorders | 2 | 2023 | 99 | 0.260 |
Why?
|
| Occludin | 3 | 2016 | 8 | 0.260 |
Why?
|
| Spinal Cord Neoplasms | 2 | 2020 | 32 | 0.260 |
Why?
|
| Angiopoietins | 3 | 2011 | 15 | 0.240 |
Why?
|
| Endothelial Growth Factors | 2 | 2002 | 11 | 0.240 |
Why?
|
| Adult | 9 | 2023 | 6924 | 0.240 |
Why?
|
| Apoptosis | 2 | 2007 | 194 | 0.230 |
Why?
|
| Pituitary Gland, Posterior | 1 | 2005 | 1 | 0.220 |
Why?
|
| Pituitary Gland, Anterior | 1 | 2005 | 2 | 0.220 |
Why?
|
| Disease Models, Animal | 4 | 2011 | 526 | 0.220 |
Why?
|
| Locus Coeruleus | 3 | 2013 | 16 | 0.220 |
Why?
|
| Plaque, Amyloid | 2 | 2015 | 85 | 0.220 |
Why?
|
| Cohort Studies | 6 | 2018 | 1416 | 0.210 |
Why?
|
| Independent Living | 3 | 2023 | 225 | 0.210 |
Why?
|
| Neurofibrillary Tangles | 4 | 2023 | 117 | 0.200 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2003 | 3 | 0.200 |
Why?
|
| Caveolae | 3 | 2011 | 17 | 0.200 |
Why?
|
| Limbic Encephalitis | 1 | 2023 | 10 | 0.200 |
Why?
|
| Motor Disorders | 1 | 2023 | 17 | 0.200 |
Why?
|
| Membrane Glycoproteins | 1 | 2003 | 47 | 0.200 |
Why?
|
| Neovascularization, Physiologic | 2 | 2019 | 23 | 0.200 |
Why?
|
| Histocytochemistry | 1 | 2003 | 12 | 0.200 |
Why?
|
| Cerebrum | 1 | 2023 | 6 | 0.190 |
Why?
|
| Atherosclerosis | 1 | 2023 | 44 | 0.190 |
Why?
|
| Meningitis | 1 | 2022 | 10 | 0.180 |
Why?
|
| Amyloid beta-Peptides | 3 | 2023 | 198 | 0.180 |
Why?
|
| Telencephalon | 1 | 2002 | 1 | 0.180 |
Why?
|
| Logistic Models | 3 | 2017 | 351 | 0.170 |
Why?
|
| Rhabdoid Tumor | 1 | 2020 | 2 | 0.170 |
Why?
|
| Late Onset Disorders | 1 | 2020 | 4 | 0.170 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2020 | 11 | 0.160 |
Why?
|
| Rats, Inbred WF | 3 | 2005 | 6 | 0.160 |
Why?
|
| Illinois | 1 | 2020 | 221 | 0.160 |
Why?
|
| Middle Aged | 9 | 2019 | 7911 | 0.150 |
Why?
|
| Coloring Agents | 2 | 2013 | 14 | 0.150 |
Why?
|
| Comorbidity | 1 | 2020 | 426 | 0.150 |
Why?
|
| Capillary Permeability | 3 | 2003 | 28 | 0.150 |
Why?
|
| Headache | 2 | 2017 | 36 | 0.150 |
Why?
|
| Motor Neurons | 1 | 2018 | 15 | 0.150 |
Why?
|
| Age Factors | 1 | 2020 | 637 | 0.140 |
Why?
|
| Movement | 1 | 2018 | 104 | 0.140 |
Why?
|
| Time Factors | 4 | 2013 | 1257 | 0.140 |
Why?
|
| Microscopy, Confocal | 2 | 2011 | 80 | 0.140 |
Why?
|
| Brain Infarction | 1 | 2018 | 63 | 0.140 |
Why?
|
| Growth Hormone-Secreting Pituitary Adenoma | 1 | 2017 | 3 | 0.140 |
Why?
|
| Facial Pain | 1 | 2017 | 7 | 0.130 |
Why?
|
| Linear Models | 1 | 2018 | 192 | 0.130 |
Why?
|
| Microvessels | 1 | 2017 | 12 | 0.130 |
Why?
|
| Phosphorylation | 2 | 2016 | 130 | 0.130 |
Why?
|
| Fragile X Syndrome | 1 | 2020 | 186 | 0.130 |
Why?
|
| Vision Disorders | 1 | 2017 | 19 | 0.130 |
Why?
|
| Hypertension | 3 | 2003 | 163 | 0.130 |
Why?
|
| Fluorescent Dyes | 2 | 2011 | 34 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factors | 2 | 2011 | 14 | 0.130 |
Why?
|
| Endothelium | 2 | 2011 | 13 | 0.130 |
Why?
|
| Tuberous Sclerosis | 1 | 2017 | 12 | 0.130 |
Why?
|
| Brain Stem | 2 | 2016 | 16 | 0.130 |
Why?
|
| Mental Status Schedule | 1 | 2017 | 66 | 0.130 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 311 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor B | 2 | 2009 | 2 | 0.120 |
Why?
|
| Epidermal Cyst | 1 | 2016 | 5 | 0.120 |
Why?
|
| Brain Chemistry | 1 | 2016 | 33 | 0.120 |
Why?
|
| United States | 1 | 2021 | 1765 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 56 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2005 | 131 | 0.120 |
Why?
|
| Central Nervous System Cysts | 1 | 2015 | 6 | 0.120 |
Why?
|
| Choroid Plexus | 2 | 2007 | 6 | 0.120 |
Why?
|
| Sphenoid Sinus | 1 | 2015 | 14 | 0.120 |
Why?
|
| Visceral Afferents | 1 | 2015 | 3 | 0.120 |
Why?
|
| Spinal Cord Dorsal Horn | 1 | 2015 | 7 | 0.110 |
Why?
|
| Skin Neoplasms | 1 | 2016 | 66 | 0.110 |
Why?
|
| Depressive Disorder, Major | 1 | 2016 | 88 | 0.110 |
Why?
|
| Urinary Incontinence | 1 | 2015 | 21 | 0.110 |
Why?
|
| Sclerosis | 1 | 2015 | 53 | 0.110 |
Why?
|
| Cell Membrane | 2 | 2007 | 85 | 0.110 |
Why?
|
| Multiple System Atrophy | 1 | 2015 | 26 | 0.110 |
Why?
|
| Skull Base Neoplasms | 1 | 2014 | 17 | 0.110 |
Why?
|
| Immunoenzyme Techniques | 2 | 2005 | 31 | 0.110 |
Why?
|
| Pineal Gland | 1 | 2014 | 3 | 0.110 |
Why?
|
| gamma-Tocopherol | 1 | 2014 | 7 | 0.110 |
Why?
|
| alpha-Tocopherol | 1 | 2014 | 11 | 0.110 |
Why?
|
| Signal Transduction | 1 | 2016 | 387 | 0.110 |
Why?
|
| Apolipoprotein E4 | 1 | 2015 | 172 | 0.100 |
Why?
|
| alpha-Synuclein | 1 | 2015 | 103 | 0.100 |
Why?
|
| Neuroma, Acoustic | 1 | 2013 | 3 | 0.100 |
Why?
|
| Biomarkers | 2 | 2007 | 474 | 0.100 |
Why?
|
| Glioblastoma | 1 | 2013 | 9 | 0.100 |
Why?
|
| Immunocompetence | 1 | 2013 | 6 | 0.100 |
Why?
|
| Mesencephalon | 1 | 2013 | 21 | 0.100 |
Why?
|
| Coccidioidomycosis | 1 | 2013 | 7 | 0.100 |
Why?
|
| Quadriplegia | 1 | 2013 | 8 | 0.100 |
Why?
|
| Radiosurgery | 1 | 2013 | 29 | 0.100 |
Why?
|
| Inflammation | 3 | 2007 | 227 | 0.100 |
Why?
|
| Ki-67 Antigen | 1 | 2013 | 18 | 0.100 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 1409 | 0.100 |
Why?
|
| Uterine Neoplasms | 1 | 2013 | 17 | 0.100 |
Why?
|
| Brain Neoplasms | 1 | 2013 | 71 | 0.100 |
Why?
|
| Psychomotor Disorders | 1 | 2013 | 9 | 0.100 |
Why?
|
| Leiomyosarcoma | 1 | 2013 | 23 | 0.100 |
Why?
|
| Vascular Diseases | 1 | 2013 | 34 | 0.100 |
Why?
|
| Neurosurgical Procedures | 1 | 2013 | 115 | 0.090 |
Why?
|
| Blood Proteins | 1 | 2011 | 17 | 0.080 |
Why?
|
| Antibodies | 1 | 2011 | 43 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2019 | 1493 | 0.080 |
Why?
|
| Aquaporin 1 | 1 | 2009 | 1 | 0.080 |
Why?
|
| Aquaporin 4 | 1 | 2009 | 1 | 0.080 |
Why?
|
| Matrix Metalloproteinases | 1 | 2009 | 18 | 0.080 |
Why?
|
| Junctional Adhesion Molecules | 1 | 2008 | 1 | 0.070 |
Why?
|
| Receptor, TIE-2 | 2 | 2005 | 2 | 0.070 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2014 | 267 | 0.070 |
Why?
|
| Sural Nerve | 1 | 2007 | 4 | 0.070 |
Why?
|
| Neural Conduction | 1 | 2007 | 11 | 0.070 |
Why?
|
| Muscle Weakness | 1 | 2007 | 27 | 0.070 |
Why?
|
| Peripheral Nerves | 1 | 2007 | 17 | 0.070 |
Why?
|
| Claudin-5 | 1 | 2007 | 1 | 0.070 |
Why?
|
| Alleles | 2 | 2020 | 165 | 0.070 |
Why?
|
| Cerebral Arteries | 1 | 2007 | 21 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2007 | 94 | 0.070 |
Why?
|
| Biopsy | 1 | 2007 | 188 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2007 | 87 | 0.060 |
Why?
|
| Skin | 1 | 2007 | 117 | 0.060 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2007 | 5 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2007 | 144 | 0.060 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2005 | 15 | 0.060 |
Why?
|
| Caspase 3 | 1 | 2005 | 17 | 0.060 |
Why?
|
| Caspases | 1 | 2005 | 22 | 0.060 |
Why?
|
| Nervous System Diseases | 1 | 2007 | 99 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2013 | 2939 | 0.060 |
Why?
|
| Prognosis | 1 | 2007 | 728 | 0.060 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2005 | 7 | 0.060 |
Why?
|
| Memory | 2 | 2018 | 213 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2007 | 341 | 0.050 |
Why?
|
| Gene Expression | 1 | 2005 | 178 | 0.050 |
Why?
|
| Myocardium | 1 | 2004 | 102 | 0.050 |
Why?
|
| Encephalitis | 1 | 2003 | 10 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2004 | 125 | 0.050 |
Why?
|
| Infarction | 1 | 2023 | 19 | 0.050 |
Why?
|
| Cell Count | 2 | 2013 | 72 | 0.050 |
Why?
|
| CpG Islands | 1 | 2003 | 43 | 0.050 |
Why?
|
| Microtomy | 1 | 2003 | 1 | 0.050 |
Why?
|
| Monosaccharides | 1 | 2003 | 1 | 0.050 |
Why?
|
| Pia Mater | 1 | 2003 | 1 | 0.050 |
Why?
|
| Serum Albumin, Radio-Iodinated | 1 | 2003 | 1 | 0.050 |
Why?
|
| Lanthanum | 1 | 2003 | 2 | 0.050 |
Why?
|
| Pericytes | 1 | 2003 | 3 | 0.050 |
Why?
|
| Tissue Embedding | 1 | 2003 | 4 | 0.050 |
Why?
|
| Tissue Fixation | 1 | 2003 | 5 | 0.050 |
Why?
|
| Capillaries | 1 | 2003 | 10 | 0.050 |
Why?
|
| Antigens | 1 | 2003 | 9 | 0.050 |
Why?
|
| Basement Membrane | 1 | 2003 | 10 | 0.050 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2003 | 4 | 0.050 |
Why?
|
| Staining and Labeling | 1 | 2003 | 15 | 0.050 |
Why?
|
| Peroxidases | 1 | 2003 | 6 | 0.050 |
Why?
|
| Vasoconstriction | 1 | 2003 | 14 | 0.050 |
Why?
|
| Antigen Presentation | 1 | 2003 | 13 | 0.050 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2003 | 17 | 0.050 |
Why?
|
| Chemokines | 1 | 2003 | 14 | 0.050 |
Why?
|
| Cats | 1 | 2003 | 28 | 0.050 |
Why?
|
| Electrophysiology | 1 | 2003 | 95 | 0.050 |
Why?
|
| Mitochondria | 1 | 2003 | 55 | 0.050 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2003 | 38 | 0.050 |
Why?
|
| Mitotic Index | 1 | 2002 | 6 | 0.050 |
Why?
|
| Bromodeoxyuridine | 1 | 2002 | 10 | 0.050 |
Why?
|
| In Situ Hybridization | 1 | 2002 | 49 | 0.050 |
Why?
|
| Lumbar Vertebrae | 2 | 2018 | 354 | 0.050 |
Why?
|
| Membrane Potentials | 1 | 2003 | 168 | 0.050 |
Why?
|
| Meninges | 1 | 2022 | 6 | 0.050 |
Why?
|
| Macrophages | 1 | 2003 | 78 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2022 | 22 | 0.050 |
Why?
|
| Cerebral Hemorrhage | 1 | 2023 | 103 | 0.050 |
Why?
|
| Mice | 2 | 2003 | 1238 | 0.050 |
Why?
|
| Lymphokines | 1 | 2002 | 10 | 0.050 |
Why?
|
| tau Proteins | 1 | 2023 | 145 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 67 | 0.050 |
Why?
|
| Calcium Signaling | 1 | 2003 | 120 | 0.040 |
Why?
|
| Cranial Fossa, Posterior | 2 | 2014 | 6 | 0.040 |
Why?
|
| Models, Biological | 1 | 2003 | 302 | 0.040 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2020 | 42 | 0.040 |
Why?
|
| Young Adult | 2 | 2015 | 1652 | 0.040 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2020 | 112 | 0.040 |
Why?
|
| Decompression, Surgical | 1 | 2020 | 117 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2019 | 2985 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2020 | 567 | 0.040 |
Why?
|
| Neuroimaging | 1 | 2019 | 100 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2018 | 85 | 0.030 |
Why?
|
| Microglia | 1 | 2018 | 107 | 0.030 |
Why?
|
| Scalp | 1 | 2016 | 5 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 56 | 0.030 |
Why?
|
| Sacrum | 1 | 2015 | 21 | 0.030 |
Why?
|
| Heterozygote | 1 | 2015 | 88 | 0.030 |
Why?
|
| Genotype | 1 | 2015 | 248 | 0.030 |
Why?
|
| Cell Nucleus Shape | 1 | 2014 | 3 | 0.030 |
Why?
|
| Cell Shape | 1 | 2014 | 6 | 0.030 |
Why?
|
| Thoracic Vertebrae | 1 | 2015 | 88 | 0.030 |
Why?
|
| Raphe Nuclei | 1 | 2013 | 5 | 0.030 |
Why?
|
| Ventral Tegmental Area | 1 | 2013 | 7 | 0.030 |
Why?
|
| Amyloid | 1 | 2012 | 37 | 0.020 |
Why?
|
| Postmortem Changes | 1 | 2012 | 22 | 0.020 |
Why?
|
| Infant | 1 | 2014 | 483 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2014 | 537 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2012 | 215 | 0.020 |
Why?
|
| Cervical Vertebrae | 1 | 2013 | 271 | 0.020 |
Why?
|
| CD59 Antigens | 1 | 2007 | 2 | 0.020 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2007 | 2 | 0.020 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2007 | 5 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2007 | 11 | 0.020 |
Why?
|
| Epithelium | 1 | 2007 | 26 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2007 | 36 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2007 | 62 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 163 | 0.020 |
Why?
|
| Necrosis | 1 | 2005 | 24 | 0.010 |
Why?
|
| Craniotomy | 1 | 2005 | 17 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2004 | 19 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2004 | 132 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 314 | 0.010 |
Why?
|
| Gene Library | 1 | 2003 | 7 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2003 | 23 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2003 | 41 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2003 | 35 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2003 | 70 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2003 | 148 | 0.010 |
Why?
|
| Pregnancy | 1 | 2003 | 324 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2003 | 462 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2003 | 375 | 0.010 |
Why?
|
| Adolescent | 1 | 2007 | 1881 | 0.010 |
Why?
|